DZ2103A1 - (Méthylsulfonyl)phenyl-2-(5H)-furannones et tant qu'inhibiteurs de cox-2. - Google Patents
(Méthylsulfonyl)phenyl-2-(5H)-furannones et tant qu'inhibiteurs de cox-2.Info
- Publication number
- DZ2103A1 DZ2103A1 DZ960147A DZ960147A DZ2103A1 DZ 2103 A1 DZ2103 A1 DZ 2103A1 DZ 960147 A DZ960147 A DZ 960147A DZ 960147 A DZ960147 A DZ 960147A DZ 2103 A1 DZ2103 A1 DZ 2103A1
- Authority
- DZ
- Algeria
- Prior art keywords
- furannones
- methylsulfonyl
- cox
- inhibitors
- phenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/24—Sulfones; Sulfoxides having sulfone or sulfoxide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/58—One oxygen atom, e.g. butenolide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/60—Two oxygen atoms, e.g. succinic anhydride
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/62—Three oxygen atoms, e.g. ascorbic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/64—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/66—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/83—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/94—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom spiro-condensed with carbocyclic rings or ring systems, e.g. griseofulvins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Ophthalmology & Optometry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Seasonings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Fats And Perfumes (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US537195P | 1995-10-13 | 1995-10-13 | |
GBGB9602939.2A GB9602939D0 (en) | 1996-02-13 | 1996-02-13 | (Methylsulfony)phenyl-2-(5h)-furanones as cox-2 inhibitors |
US1163796P | 1996-02-14 | 1996-02-14 | |
GBGB9605645.2A GB9605645D0 (en) | 1996-03-18 | 1996-03-18 | (Methylsulfonyl)phenyl-2-(5H)- furanones as cox-2 inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
DZ2103A1 true DZ2103A1 (fr) | 2002-07-22 |
Family
ID=27451401
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DZ960147A DZ2103A1 (fr) | 1995-10-13 | 1996-10-09 | (Méthylsulfonyl)phenyl-2-(5H)-furannones et tant qu'inhibiteurs de cox-2. |
Country Status (39)
Country | Link |
---|---|
EP (1) | EP0863891B1 (fr) |
JP (2) | JP3337476B2 (fr) |
KR (1) | KR100354940B1 (fr) |
CN (1) | CN1203066C (fr) |
AT (1) | ATE229515T1 (fr) |
AU (1) | AU703871B2 (fr) |
BG (1) | BG63391B1 (fr) |
BR (1) | BR9611015A (fr) |
CA (1) | CA2233178C (fr) |
CO (1) | CO4770965A1 (fr) |
CZ (1) | CZ295764B6 (fr) |
DE (2) | DE122005000010I2 (fr) |
DK (1) | DK0863891T3 (fr) |
DZ (1) | DZ2103A1 (fr) |
EA (1) | EA000795B1 (fr) |
EE (1) | EE03969B1 (fr) |
ES (1) | ES2187675T3 (fr) |
HK (1) | HK1016980A1 (fr) |
HR (1) | HRP960458B1 (fr) |
HU (1) | HU222785B1 (fr) |
IL (1) | IL123699A (fr) |
IS (1) | IS2148B (fr) |
LU (1) | LU91145I2 (fr) |
MX (1) | MX9802836A (fr) |
MY (1) | MY141773A (fr) |
NL (1) | NL300175I2 (fr) |
NO (1) | NO321042B1 (fr) |
NZ (1) | NZ319090A (fr) |
PE (1) | PE17198A1 (fr) |
PL (1) | PL188918B1 (fr) |
PT (1) | PT863891E (fr) |
RO (1) | RO119884B1 (fr) |
RS (1) | RS49885B (fr) |
SA (1) | SA96170405B1 (fr) |
SK (1) | SK282639B6 (fr) |
TR (1) | TR199800585T2 (fr) |
TW (1) | TW426679B (fr) |
UA (1) | UA57002C2 (fr) |
WO (1) | WO1997014691A1 (fr) |
Families Citing this family (68)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6515014B2 (en) | 1995-06-02 | 2003-02-04 | G. D. Searle & Co. | Thiophene substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors |
WO1998041516A1 (fr) * | 1997-03-14 | 1998-09-24 | Merck Frosst Canada & Co. | (methylsufonyl)phenyl-2-(5h)-furanones a liaison oxygene, utilises comme inhibiteurs de cyclo-oxygenase-2 |
IL125686A (en) | 1996-02-13 | 2002-11-10 | Zeneca Ltd | Quinazoline derivatives, processes for their preparation, pharmaceutical preparations containing them and their use in the manufacture of a drug with an anti-angiogenic effect and / or an effect of reducing vascular permeability |
WO1997032856A1 (fr) | 1996-03-05 | 1997-09-12 | Zeneca Limited | Derives de 4-anilinoquinazoline |
US5883267A (en) * | 1996-05-31 | 1999-03-16 | Merck & Co., Inc. | Process for making phenyl heterocycles useful as cox-2 inhibitors |
US6071954A (en) * | 1997-03-14 | 2000-06-06 | Merk Frosst Canada, Inc. | (methylsulfonyl)phenyl-2-(5H)-furanones with oxygen link as COX-2 inhibitors |
US6525053B1 (en) | 1997-08-22 | 2003-02-25 | Abbott Laboratories | Prostaglandin endoperoxide H synthase biosynthesis inhibitors |
US6307047B1 (en) | 1997-08-22 | 2001-10-23 | Abbott Laboratories | Prostaglandin endoperoxide H synthase biosynthesis inhibitors |
WO1999015513A1 (fr) * | 1997-09-24 | 1999-04-01 | Merck & Co., Inc. | Procede de preparation de 3-aryloxy, 4-aryl furan-2-ones utiles comme inhibiteurs de cox-2 |
FR2770131A1 (fr) * | 1997-10-27 | 1999-04-30 | Union Pharma Scient Appl | Nouvelle association pharmaceutique a activite analgesique |
GB2330833A (en) * | 1997-10-29 | 1999-05-05 | Merck & Co Inc | PREPARATION OF 4-(4-Methylsulfonylphenyl)-2-furanones USEFUL AS COX-2 INHIBITORS |
JP2001521932A (ja) * | 1997-10-30 | 2001-11-13 | メルク フロスト カナダ アンド カンパニー | 選択的シクロオキシゲナーゼ−2−阻害剤としてのジアリール−5−アルキル−5−メチル−2(5h)−フラノン |
US6133292A (en) * | 1997-10-30 | 2000-10-17 | Merck Frosst Canada & Co. | Diaryl-5-alkyl-5-methyl-2-(5H)-furanones as selective cyclooxygenase-2-inhibitors |
FR2771005B1 (fr) * | 1997-11-18 | 2002-06-07 | Union Pharma Scient Appl | Nouvelle association pharmaceutique a activite analgesique |
US6136804A (en) | 1998-03-13 | 2000-10-24 | Merck & Co., Inc. | Combination therapy for treating, preventing, or reducing the risks associated with acute coronary ischemic syndrome and related conditions |
JP2002506024A (ja) * | 1998-03-13 | 2002-02-26 | メルク エンド カムパニー インコーポレーテッド | 急性冠動脈虚血症候群および関連状態に対する併用療法および組成物 |
ES2140354B1 (es) * | 1998-08-03 | 2000-11-01 | S A L V A T Lab Sa | Imidazo (1,2a) azinas sustituidas como inhibidores selectivos de la cox-2. |
WO2000024711A1 (fr) * | 1998-10-27 | 2000-05-04 | Merck & Co., Inc. | Synthese des hydroxyketones de methylthiophenyle |
PL204249B1 (pl) * | 1999-04-14 | 2009-12-31 | Pacific Corp | Pochodne 4,5-diarylo-3(2H)-furanonu ich zastosowanie oraz sposób wytwarzania pochodnych 4,5-diarylo-2,2-dimetylo-3(2H)-furanonu |
DE69940922D1 (de) * | 1999-10-08 | 2009-07-09 | Merial Sas | Polymorphe Form B von 3-(Cyclopropylmethoxy)-4-i4-(methylsulfonyl)phenyl -5,5-dimethyl-5H-furan-2-on |
FR2799462B1 (fr) | 1999-10-08 | 2004-05-28 | Merial Sas | Procede de preparation d'inhibiteurs cox-2 |
IL149034A0 (en) | 1999-11-05 | 2002-11-10 | Astrazeneca Ab | Quinazoline derivatives as vegf inhibitors |
ES2208227T3 (es) | 1999-12-03 | 2004-06-16 | Pfizer Products Inc. | Compuestos de heteroarilfenilpirazol como agentes antiinflamatorios/analgesicos. |
WO2001040216A1 (fr) | 1999-12-03 | 2001-06-07 | Pfizer Products Inc. | Derive heterocyclo-alkylsulfonyle pyrazole en tant qu'agents anti-inflammatoires/analgesiques |
DE60001623T2 (de) | 1999-12-03 | 2003-12-18 | Pfizer Products Inc., Groton | Sulfamoylheteroarylpyrazolverbindungen zur Verwendung als analgetisches/entzündungshemmendes Mittel |
DE60004001T2 (de) | 1999-12-03 | 2004-04-15 | Pfizer Products Inc., Groton | Acetylenderivate zur Verwendung als schmerzstillendes oder entzündungshemmendes Mittel |
CA2396593A1 (fr) * | 2000-01-28 | 2001-08-02 | Merck & Co., Inc. | Traitement ou prevention du cancer de la prostate avec un medicament inhibiteur selectif de cox-2 |
EP1273582B1 (fr) | 2001-07-05 | 2005-06-29 | Pfizer Products Inc. | Pyrazoles heterocycliques alkylsulfoniques comme agents anti-inflammatoires/analgésiques |
AR038957A1 (es) | 2001-08-15 | 2005-02-02 | Pharmacia Corp | Terapia de combinacion para el tratamiento del cancer |
GT200200183A (es) | 2001-09-28 | 2003-05-23 | Procedimiento para preparar derivados de heterocicloalquilsulfonil pirazol | |
WO2003037336A1 (fr) | 2001-11-02 | 2003-05-08 | Pfizer Products Inc. | Derives de 1-(5-sulfonyl-pyridin-2-yl)-5-(methylidene-cycloalkylmethoxy)-1h-pyrazole-4-carbonitrile et autres composes utilises en tant qu'inhibiteurs de la cyclooxygenase dans le traitement de l'arthrite, de la neurodegeneration et du cancer du colon |
UY27939A1 (es) | 2002-08-21 | 2004-03-31 | Glaxo Group Ltd | Compuestos |
CN1309717C (zh) * | 2003-06-03 | 2007-04-11 | 李小虎 | 4-芳基-5h-噻吩-2-酮衍生物、其制法和用途 |
US8067464B2 (en) | 2004-10-04 | 2011-11-29 | Nitromed, Inc. | Compositions and methods using apocynin compounds and nitric oxide donors |
MX2007007830A (es) | 2004-12-23 | 2007-07-25 | Glaxo Group Ltd | Compuestos de piridina para el tratamiento de enfermedades mediadas por prostaglandina. |
WO2007016677A2 (fr) | 2005-08-02 | 2007-02-08 | Nitromed, Inc. | Composes antimicrobiens promoteurs d'oxyde nitrique, compositions et procedes d'utilisation |
BRPI0616552A2 (pt) * | 2005-08-19 | 2011-06-21 | Emisphere Tech Inc | composto de ciclopropila, composição para liberação de ativos, forma unitária de dosagem, método para administrar um agente biologicamente ativo e método para preparar uma composição |
EP2007705A4 (fr) | 2006-03-29 | 2011-09-07 | Nicox Sa | Prostaglandines amplificatrices d'oxyde nitrique, compositions et méthodes d'utilisation |
EP1878717A1 (fr) | 2006-07-14 | 2008-01-16 | Bayer Schering Pharma Aktiengesellschaft | Benzylamines, leur procédé de préparation, leur utilisation comme agents anti-inflammatoires |
GB0704407D0 (en) | 2007-03-07 | 2007-04-18 | Glaxo Group Ltd | Compounds |
US7943658B2 (en) | 2007-07-23 | 2011-05-17 | Bristol-Myers Squibb Company | Indole indane amide compounds useful as CB2 agonists and method |
EP2062880A1 (fr) * | 2007-11-22 | 2009-05-27 | Bayer Schering Pharma Aktiengesellschaft | 5-[(3,3,3-Trifluoro-2-hydroxy-1-arylpropyl)amino]-1H-quinolin-2-ones, procédé pour leur production et leur utilisation comme agents anti-inflammatoires |
GB0813142D0 (en) | 2008-07-17 | 2008-08-27 | Glaxo Group Ltd | Novel compounds |
GB0813144D0 (en) | 2008-07-17 | 2008-08-27 | Glaxo Group Ltd | Novel compounds |
EP2177215A1 (fr) | 2008-10-17 | 2010-04-21 | Laboratorios Del. Dr. Esteve, S.A. | Co-cristaux de tramadol et NSAID |
WO2011012622A1 (fr) | 2009-07-30 | 2011-02-03 | Glaxo Group Limited | Dérivés de benzoxazinone pour traiter des troubles induits par glytl |
WO2011023753A1 (fr) | 2009-08-27 | 2011-03-03 | Glaxo Group Limited | Dérivés de benzoxazine inhibiteurs du transport de glycine |
GB201000685D0 (en) | 2010-01-15 | 2010-03-03 | Glaxo Group Ltd | Novel compounds |
GB201007791D0 (en) | 2010-05-10 | 2010-06-23 | Glaxo Group Ltd | Novel compounds |
GB201007789D0 (en) | 2010-05-10 | 2010-06-23 | Glaxo Group Ltd | Novel Compound |
WO2012004604A1 (fr) | 2010-07-09 | 2012-01-12 | Convergence Pharmaceuticals Limited | Composés de tétrazole comme bloqueurs des canaux calciques |
JP6058556B2 (ja) | 2011-01-19 | 2017-01-11 | クオンベルゲンセ プハルマセウトイカルス リミテッド | CaV2.2カルシウムチャンネルブロッカーとしてのピペラジン誘導体 |
GB201122113D0 (en) | 2011-12-22 | 2012-02-01 | Convergence Pharmaceuticals | Novel compounds |
AU2013317791B2 (en) | 2012-09-21 | 2018-05-10 | Midwestern University | Inhibitors of beta-hydrolase for treatment of cancer |
GB201417497D0 (en) | 2014-10-03 | 2014-11-19 | Convergence Pharmaceuticals | Novel use |
GB201417500D0 (en) | 2014-10-03 | 2014-11-19 | Convergence Pharmaceuticals | Novel use |
GB201417499D0 (en) | 2014-10-03 | 2014-11-19 | Convergence Pharmaceuticals | Novel use |
CN104803956A (zh) * | 2015-03-06 | 2015-07-29 | 江苏天和制药有限公司 | 非罗考昔的一种合成方法 |
WO2016177776A1 (fr) | 2015-05-04 | 2016-11-10 | Academisch Medisch Centrum | Biomarqueurs pour la détection de l'insensibilité à l'aspirine |
ES2857128T3 (es) | 2017-04-14 | 2021-09-28 | Cosma S P A | Procedimiento para la síntesis de firocoxib |
CN108178724B (zh) * | 2017-12-22 | 2020-09-11 | 四川大学 | 化合物的制备方法 |
CN110240537B (zh) * | 2019-05-22 | 2022-06-21 | 成都阿奇生物医药科技有限公司 | 一种茚氧乙酸类化合物及其制备方法和用途 |
CN110452199B (zh) * | 2019-09-03 | 2021-03-30 | 山东鲁抗舍里乐药业有限公司 | 一种非罗考昔的制备方法 |
CN110452198B (zh) * | 2019-09-03 | 2021-03-26 | 山东鲁抗舍里乐药业有限公司 | 一种非罗考昔的制备方法 |
DE102019214427A1 (de) | 2019-09-23 | 2021-03-25 | Multivac Marking & Inspection Gmbh & Co. Kg | Etikettierer mit Montageeinrichtung für Andrückelement |
CN110746390B (zh) * | 2019-11-14 | 2022-12-30 | 中国科学技术大学 | 制备5-甲酰基-2-呋喃甲酸酯的方法 |
WO2022195579A1 (fr) | 2021-03-15 | 2022-09-22 | Saul Yedgar | Dipalmitoyl-phosphatidyl-éthanol-amine conjuguée à l'acide hyaluronique en combinaison avec des médicaments anti-inflammatoires non stéroïdiens (ains) pour traiter ou soulager des maladies inflammatoires |
CN113248458B (zh) * | 2021-05-27 | 2022-09-27 | 陕西省煤田地质集团有限公司 | 一种α-羰基酰胺化合物的制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5474995A (en) * | 1993-06-24 | 1995-12-12 | Merck Frosst Canada, Inc. | Phenyl heterocycles as cox-2 inhibitors |
EP0799218B1 (fr) * | 1994-12-21 | 2003-02-19 | Merck Frosst Canada & Co. | Diaryl-2-(5h)-furanones inhibiteurs de cox-2 |
-
1996
- 1996-09-10 UA UA98041875A patent/UA57002C2/uk unknown
- 1996-10-07 HR HR960458A patent/HRP960458B1/xx not_active IP Right Cessation
- 1996-10-08 MY MYPI96004167A patent/MY141773A/en unknown
- 1996-10-09 PL PL96326203A patent/PL188918B1/pl unknown
- 1996-10-09 PE PE1996000715A patent/PE17198A1/es not_active IP Right Cessation
- 1996-10-09 EE EE9800080A patent/EE03969B1/xx active Protection Beyond IP Right Term
- 1996-10-09 HU HU9802506A patent/HU222785B1/hu active Protection Beyond IP Right Term
- 1996-10-09 KR KR10-1998-0702755A patent/KR100354940B1/ko not_active IP Right Cessation
- 1996-10-09 DE DE200512000010 patent/DE122005000010I2/de active Active
- 1996-10-09 DK DK96932417T patent/DK0863891T3/da active
- 1996-10-09 TR TR1998/00585T patent/TR199800585T2/xx unknown
- 1996-10-09 DZ DZ960147A patent/DZ2103A1/fr active
- 1996-10-09 WO PCT/CA1996/000682 patent/WO1997014691A1/fr active IP Right Grant
- 1996-10-09 JP JP51537197A patent/JP3337476B2/ja not_active Expired - Lifetime
- 1996-10-09 CA CA002233178A patent/CA2233178C/fr not_active Expired - Lifetime
- 1996-10-09 CZ CZ19981101A patent/CZ295764B6/cs not_active IP Right Cessation
- 1996-10-09 EA EA199800290A patent/EA000795B1/ru not_active IP Right Cessation
- 1996-10-09 IL IL12369996A patent/IL123699A/en not_active IP Right Cessation
- 1996-10-09 ES ES96932417T patent/ES2187675T3/es not_active Expired - Lifetime
- 1996-10-09 AT AT96932417T patent/ATE229515T1/de active
- 1996-10-09 EP EP96932417A patent/EP0863891B1/fr not_active Expired - Lifetime
- 1996-10-09 CN CNB961976098A patent/CN1203066C/zh not_active Expired - Lifetime
- 1996-10-09 PT PT96932417T patent/PT863891E/pt unknown
- 1996-10-09 SK SK450-98A patent/SK282639B6/sk not_active IP Right Cessation
- 1996-10-09 NZ NZ319090A patent/NZ319090A/xx not_active IP Right Cessation
- 1996-10-09 AU AU71236/96A patent/AU703871B2/en not_active Expired
- 1996-10-09 RO RO98-00856A patent/RO119884B1/ro unknown
- 1996-10-09 BR BR9611015-5A patent/BR9611015A/pt not_active IP Right Cessation
- 1996-10-09 DE DE69625374T patent/DE69625374T2/de not_active Expired - Lifetime
- 1996-10-10 CO CO96053995A patent/CO4770965A1/es unknown
- 1996-10-10 RS YUP-548/96A patent/RS49885B/sr unknown
- 1996-10-12 TW TW085112463A patent/TW426679B/zh not_active IP Right Cessation
- 1996-10-30 SA SA96170405A patent/SA96170405B1/ar unknown
-
1998
- 1998-03-20 IS IS4695A patent/IS2148B/is unknown
- 1998-04-08 NO NO19981628A patent/NO321042B1/no not_active IP Right Cessation
- 1998-04-08 MX MX9802836A patent/MX9802836A/es unknown
- 1998-05-04 BG BG102425A patent/BG63391B1/bg unknown
-
1999
- 1999-05-07 HK HK99102061A patent/HK1016980A1/xx not_active IP Right Cessation
-
2000
- 2000-12-01 JP JP2000366579A patent/JP4068802B2/ja not_active Expired - Lifetime
-
2005
- 2005-02-14 NL NL300175C patent/NL300175I2/nl unknown
- 2005-03-09 LU LU91145C patent/LU91145I2/fr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DZ2103A1 (fr) | (Méthylsulfonyl)phenyl-2-(5H)-furannones et tant qu'inhibiteurs de cox-2. | |
IL123002A0 (en) | 1-Phenyl-2- phenylacetoxy- ethanone derivatives | |
DE69618820D1 (de) | 3,4-diaryl-2-hydroxy-2,5-dihydrofurane als wirkstoffvorstufen von cox-2 inhibitoren | |
PT828724E (pt) | Diaril-5-oxigenadas-2-(5h)-furanonas comoinibidoras de cox-2 | |
DE69529690D1 (de) | Diaryl-2(5h)-fuaranone als cox-2-inhibitoren | |
DE69816047D1 (en) | (methylsulfonyl)phenyl-2-(5h)-furanone mit sauerstoff-bindung als cox-2-hemmer | |
DE69715173D1 (en) | Bisarylcyclobutenderivate als cyclooxygenasehemmer | |
IL125441A0 (en) | Novel diphenyl stilbenes and pharmaceutical compositions thereof for treatment of cox-2 mediated diseases | |
MY119407A (en) | 3-phenyl-4-(4(methylsulfonyl)phenyl)-2-(5h)-furanone as a cox-2 inhibitor. |